Literature DB >> 22622656

Fusion between tumor cells enhances melanoma metastatic potential.

Ruifang Mi1, Chunxiao Pan, Xiaocui Bian, Liqiang Song, Wenjia Tian, Fang Cao, Juan Yin, Haiyong Peng, Jianhui Ma.   

Abstract

PURPOSE: Malignant melanoma, characterized by early distant metastasis to the lungs and brain, is a leading cause of mortality related to skin cancer. Cell fusion and the subsequent aneuploidy, commonly observed in melanoma, are associated with poor prognosis. However, the pathological consequences of cell fusion in melanoma remain unknown. Therefore, the present study aims to investigate the pathological consequences of cell fusion in melanoma and the mechanism of melanoma metastasis.
METHODS: Phytohemagglutinin-polyethylene glycol (PHA-PEG) fusion method was developed for the fusion of tumor cells. Melanoma cells were fused through the improved PHA-PEG fusion method and obtained by fluorescence-activated cell sorting. DNA content was analyzed through flow cytometry. Cell proliferation rate was detected by cell culture in vitro, and the cell number was counted daily. To detect the tumor growth rate in vivo, cells were injected subcutaneously and the tumor volumes were measured using a vernier caliper. To analyze the tumor metastatic potential, cells were injected intravenously, and the collected lung-metastasis samples were weighed by an electronic balance and the surface nodules were counted.
RESULTS: We established an improved phytohemagglutinin-polyethylene glycol fusion method and successfully obtained stable melanoma tumor-tumor cell fusion hybrids. Cell size, DNA content, and chromosome numbers of the fusion hybrids were approximately twice those of the parents. The metastatic potential of the fusion hybrids was dramatically enhanced, in contrast to their proliferation rate. Their metastasis was specific to the lungs.
CONCLUSIONS: We developed a highly efficient cell fusion method that can be applied in many fields, particularly cancer research. Our study has proven that tumor-tumor cell fusion hybrids in melanoma can acquire enhanced and specific metastatic potential. Thus, blockage of cell fusion may be a new strategy for melanoma metastasis therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622656     DOI: 10.1007/s00432-012-1242-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

Review 1.  Cell fusion as a hidden force in tumor progression.

Authors:  Xin Lu; Yibin Kang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

2.  The analysis of malignancy by cell fusion: the position in 1988.

Authors:  H Harris
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

3.  Pea phytohemagglutinin selective agglutination of tumour cells.

Authors:  P Veselý; G Entlicher; J Kocourek
Journal:  Experientia       Date:  1972-09-15

Review 4.  Early detection and treatment of skin cancer.

Authors:  A F Jerant; J T Johnson; C D Sheridan; T J Caffrey
Journal:  Am Fam Physician       Date:  2000-07-15       Impact factor: 3.292

Review 5.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

Review 6.  Chromosome aberrations in solid tumors.

Authors:  Donna G Albertson; Colin Collins; Frank McCormick; Joe W Gray
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

7.  Lung metastasis genes couple breast tumor size and metastatic spread.

Authors:  Andy J Minn; Gaorav P Gupta; David Padua; Paula Bos; Don X Nguyen; Dimitry Nuyten; Bas Kreike; Yi Zhang; Yixin Wang; Hemant Ishwaran; John A Foekens; Marc van de Vijver; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

Review 8.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 9.  Aneuploidy and cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Cell hybridization and cell agglutination. II. Enhancement of cell hybridization by polycations.

Authors:  Y Matsuya; I Yamane
Journal:  J Cell Sci       Date:  1985-10       Impact factor: 5.285

View more
  5 in total

1.  Cell-cell fusion as a mechanism of DNA exchange in cancer.

Authors:  Stephen C Searles; Endi K Santosa; Jack D Bui
Journal:  Oncotarget       Date:  2017-12-27

2.  Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties.

Authors:  Sera Selina Fahlbusch; Silvia Keil; Jörg T Epplen; Kurt S Zänker; Thomas Dittmar
Journal:  BMC Cancer       Date:  2020-05-19       Impact factor: 4.430

Review 3.  Cell Fusion in Human Cancer: The Dark Matter Hypothesis.

Authors:  Julian Weiler; Thomas Dittmar
Journal:  Cells       Date:  2019-02-07       Impact factor: 6.600

4.  Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics.

Authors:  Jessica Dörnen; Ola Myklebost; Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 5.  The Fate of Fusions.

Authors:  Gary Clawson
Journal:  Cells       Date:  2018-12-29       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.